SlideShare a Scribd company logo
Speaker: Dr. Dibbendhu Khanra
Chairperson: Dr. A.K. Banerjee
Calcium
an unparallel hero
 most abundant mineral of body
 maintenance of strong bones
 neuro-mascular action
 blood clotting, blood pressure

 hormone regulation
-most over-the-counter sold drug
- 43% Indian women on supplement
- prescribed by doctors commonly
Calciuma sinister in disguise

HypercalcaemiaToday’s concern!
..Some cases..
3
Mr. K is a 41 year old patient
– Mild depression
– Behavioral abnormality
– Headache
– Fatigue
– Difficulty concentrating
– TSH - 2.06 (0.5 – 4.00)
– calcium 12.4 mg/dl
(8.4 – 10.4 mg/dl)


Mrs. C is a 57 year old patient, well



t-score – 1.3 (spine), 2. 8 (femur)



Calcium – 12. 5 (8.4 – 10.4 mg/dl)



weight loss and generalised weakness



Cough and hemoptysis
•
•
•
•
•
•
•
•

A 58-year-woman presented to ER
progressive Multiple sclerosis
Osteoporosis
calcium, 600 mg, 3 times daily
5000-IU cholecalciferol supplement OD
tremors
Altered sensorium
serum calcium 15.2 mg/dL
•
•
•
•
•
•

30-year-old female
Fever, cough
Polyuria, polydypsia, GI upset
constipation, confusion, headache
CECT chest – hilar lympahedenopathy
serum calcium, 13.8 mg/d
•
•
•
•
•

50-year-old male
Diabetic for 10 years
Poorly controlled with OHA
HTN, anasarca, anaemia
serum calcium 14.8 mg/d







Calcium metabolism
Defining hypercalcaemia
Causes of hypercalcaemia
Cl/f of hypercalceimia
Diagnosis to hypercalcaemia
Management
10
11
13
Causes

PTH

Genetic

 Ca++

Vitamin
D

Endocrine
Malignancy
Medicines
Renal
‘stone’

Abdominal
‘moan’

Skeletal
‘bone’

Psychis
‘groan’

Also…

15
Digitalis toxicity
A = high calcium levels means
primary hyperparathyroidism
unless the PTH is near zero

B = normocalcemic" hyperparathyroidism.
this is the only group that we believe should
have a urinary calcium level performed
It is IMPOSSIBLE to tell the difference between
FHH and primary hyperparathyroidism
based upon the results of a 24-hour urine test

1. Urinary calcium can be
anything (very low to very high)
in Pr HyperPTHism.
2. The arbitrary cut off of urinary
ca excretion/ 24 hr 100 lacks any
rationality.
3. Nor elevated serum ca neither
elevated urinary ca has any
association with renal stones.
4. Low urinary ca does not always
mean FHH.
FHH is so rare, that few doctors will ever see it.
FHH is diagnosed incorrectly about 95-99% of the time
Corrected serum calcium=
Ionized calcium + 0.8(4-serum albumin)

calcium is high and PTH
is high, d/g is primary
hyperparathyroidism.
IF calcium Familial
is mildly
Hypocalciuric
raised in background of
Hypercalcemia
Sestamibi
highly
elevated
N-scan
PTH, then urinary ca can
be ordered to rule out
FHH

19
Neuropsychiatric complaints
Calcium 12.4 mg/dl
iPTH – 509 (12-72 pg/ml)

Thallium subtraction study:
Left lower lobe parathyroid adenoma
Weight loss and generalised weakness
Calcium – 12. 5 (8.4 – 10.4 mg/dl)
iPTH 21 (10 – 65.0 pg/ml)
PTHrp - elevated

Lung biopsy with IHC:
Well differentiated, low grade squamous cell lung carcinoma
•
•
•
•

calcium, cholecalciferol supplement
serum calcium14.6 mg/dL (15.2 mg/dL)
iPTH - 4 pg/mL (N12-65 pg/mL
25-OH D level 103 ng/mL (N>30 ng/ml)

Vit D overdose
22
•
•
•
•
•

CECT chest – hilar lympahedenopathy
serum calcium, 13.8 mg/d
iPTH - 4 pg/mL (N12-65 pg/mL
1, 25-OH D level elevated
Serum ACEase – highly raised

Hilar LN Bx – non caseating granulomas
Sarcoidosis
23
•
•
•
•

T2DM
CKD
serum calcium 14.8 mg/d
iPTH – 209 (12-72 pg/ml)

Hypercalcemia Associated with Renal Failure
Hypercalcemia Associated with Renal Failure
Secondary Hyperparathyroidism
Hypocalcaemia is the common denominator
Reversible (adaptive) growth of parathyroid gland
• Resistance to the normal level of PTH
• Increased level of FGF23
• Reduction in 1,25(OH)2 vitamin D

Tertiary Hyperparathyroidism
• Long-standing, inadequately treated chronic renal failure
• True clonal outgrowth (irreversible)
25
Observation

Pharmacological
Non
Pharmacological
Surgery

Dialysis
Critical - > 14 mg %

1

Moderate - 12 to 14 mg %

2

Mild – 10.4 to 11.9 mg %

3

• Aggressive therapy
• Start therapy
• When symptomatic
• When PrHyperPTHism
• No therapy
• Except PrHyperPTHism

Normal – 8.5 to 10.3 mg %

Hypercalcaemia should always be treated

27
- thiazide and lithium
- volume depletion

- prolonged bed rest or inactivity
- high calcium diet (>1000 mg/day)

28
A

B

I.V. Saline
Hydration

Bisphosphonates

Dexa
methasone

Calcitonin

D

C

29
Dr. Harold Copp isolated
calcitonin from salmon sperm
Bisphos
phonate:
MOA

Osteonecrosis
of Jaw (ONJ)
mandible > maxilla
Matrix metalloproteinase 2
Treating hypercalcaemia is multidrug approach

In HF, CKD; lowers ca by 1-3 mg/dl
Routine use not recommended

Do not give bisphosphonates until patient is fully rehydrated
contraindicated in patients with cr cl <10 mL/min
Caution with NSAIDS, ACE inhibitors, aminoglycosides

Calcitonin and hydration provide a rapid
reduction, while a bisphosphonate provides a sustained
effect
Monitoring

Surgery
• Serum calcium level

 Mildly elevated calcium
> 1 mg % above normal
 No previous episodes of
• Creatinine clearance
life threatening
hypercalcemia
< 60 ml/minute
 Normal renal function
• Bone density: T score <–2.5
 Normal bone status
at Any of 3 sites
• Age younger than 50 years
Serum ca
serum creatinine
Bone density

Significant symptoms
– Rx surgery

33
Minimally Invasive Parathyroidectomy (MIP)

 an outpatient procedure
 Pre-op localization with Sestamibi Tc scan
 cervical block anesthesia
 minimal surgical incision
 Intra-op PTH level obtained before and 5 mins after removal
 If PTH levels fall by greater than 50% operation terminated
 IF PTH Levels fall by less than 50%, full neck exploration
 clear-cut cost benefit
 Accepted in asymptomatic patients
 not proper for multiple tumour or large tumours
• If an enlarged gland is found, a
• all four glands be
normal gland should be sought.
sought
• if an intra-operative frozen
section biopsy of a normal-sized • most of the total
parathyroid
tissue
second
gland
confirms
its
mass be removed.
histologic normality, no further
exploration, biopsy, or excision is • unnecessary surgery
& un-acceptable rate
needed.
of hypoparathyroidism
• recurrence
rate
of
hyperand hypocalcamia.
parathyroidism may be high if a
second abnormal gland is
missed.
35
• totally remove three
glands with partial
excision of the fourth
gland
• care is taken to leave
a good blood supply
for the remaining
gland

• total parathyroidectomy with
immediate transplantation of
a portion of a removed,
minced parathyroid gland
into the muscles of the
forearm
• surgical excision is easier
from the ectopic site in the
arm if there is recurrent
hyperfunction

36
 calcium 12.4 mg/dl
(8.4 – 10.4 mg/dl)
 parathyroid adenoma
 M/N= Surgery (MIP)
 Malignancy related
hypercalcaemia
(Breast, Lung, Lymphoma,
Thyroid, Kidney, Prostate,
Multiple Myeloma)
 N Saline

 calcitonin
 Zoledronic acid
• Vit D overdose
• Half life of Vit D is very short
no further treatment required
• Withhold Vit D
• Steroid can be used

39
•
•
•
•

Acute symptomatic hypercalcaemia
Sarcoidosis (granulomatous disease; DHCC related)
NS
Steroid

40
• Hypercalcemia Associated with Renal Failure
• Secondary hyperparathyroidism
• calcitriol
• Dialysis if life threatening
Secondary hyperparatyroidism
• restriction of dietary phosphate,
• the use of non-absorbable antacids
• careful, selective addition of calcitriol
Tertiary Hyperparatyroidism
• Partial removal of parathyroid gland
42
S
U
M
M
A
R
Y

Dialysis

Controversial

Malignancy or Vit D
associated cases
Avoid factors
that can
aggravate
hypercalcemia

In CKD

43
• Most common cause of hypercalcaemia is primary
hyperparathyroidism
• Any hypercalcaemia should be worked up and treated.
• First investigation to seek for is an intact PTH
• Surgery is often provided to apparently aysmptomtic
patients of primary hyperparathyroidism
• FHH, practically does NOT occur
• Hydration is the mainstay of therapy
• Managing hypercalcaemia is a multidrug approach
• Calcitriol can be given in CKD associated hypercalaemia
THANK YOU

ddk3987@gmail.com

45

More Related Content

What's hot

Contrast Induced Nephropathy
Contrast Induced NephropathyContrast Induced Nephropathy
Contrast Induced Nephropathy
Aris Tsalouchos
 
Sodium correction formula
Sodium correction formulaSodium correction formula
Sodium correction formula
Dr. Ravikiran H M Gowda
 
Potassium Management
Potassium ManagementPotassium Management
Potassium Management
cap_0009
 
Surviving Sepsis Guidelines 2016
Surviving Sepsis Guidelines 2016Surviving Sepsis Guidelines 2016
Surviving Sepsis Guidelines 2016
Sun Yai-Cheng
 
Anticoagulation in neurosurgery heparin warfarin_ppt
Anticoagulation in neurosurgery heparin warfarin_pptAnticoagulation in neurosurgery heparin warfarin_ppt
Anticoagulation in neurosurgery heparin warfarin_ppt
MQ_Library
 
hypokalemia, diagnosis and management
hypokalemia, diagnosis and managementhypokalemia, diagnosis and management
hypokalemia, diagnosis and management
Sheila Ferrer
 
Aldosterone in diabetes and other kidney diseases
Aldosterone in diabetes and other kidney diseasesAldosterone in diabetes and other kidney diseases
Aldosterone in diabetes and other kidney diseases
Christos Argyropoulos
 
Esc 2020 guidelines for the management of acute coronary
Esc 2020 guidelines for the management of acute coronaryEsc 2020 guidelines for the management of acute coronary
Esc 2020 guidelines for the management of acute coronary
Himanshu Rana
 
Sepsis and septic shock guidelines 2021. part 1
Sepsis and septic shock guidelines 2021. part 1Sepsis and septic shock guidelines 2021. part 1
Sepsis and septic shock guidelines 2021. part 1
MEEQAT HOSPITAL
 
Drug modification in crrt
Drug modification in crrt Drug modification in crrt
Drug modification in crrt
krishnaswamy sampathkumar
 
CONTRAST INDUCED NEPHROPATHY(CI-AKI)
CONTRAST INDUCED NEPHROPATHY(CI-AKI)CONTRAST INDUCED NEPHROPATHY(CI-AKI)
CONTRAST INDUCED NEPHROPATHY(CI-AKI)
Praveen Nagula
 
Contrast Nephropathy AKI
Contrast Nephropathy AKI  Contrast Nephropathy AKI
Contrast Nephropathy AKI
Manish Singla
 
Novel Oral Anticoagulants (NOACs) in CKD & Dialysis Patients - How to Use? Wh...
Novel Oral Anticoagulants (NOACs) in CKD & Dialysis Patients - How to Use? Wh...Novel Oral Anticoagulants (NOACs) in CKD & Dialysis Patients - How to Use? Wh...
Novel Oral Anticoagulants (NOACs) in CKD & Dialysis Patients - How to Use? Wh...
NephroTube - Dr.Gawad
 
Sepsis presentation by shami
Sepsis presentation by shami Sepsis presentation by shami
Sepsis presentation by shami
Dr Shami Bhagat
 
Anemia in CKD
Anemia in CKDAnemia in CKD
Anemia in CKD
Sariu Ali
 
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEFSimultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
Duke Heart
 
Hypoglycemia & Management of Diabetes in CKD Stage V
Hypoglycemia & Management of Diabetes in CKD Stage VHypoglycemia & Management of Diabetes in CKD Stage V
Hypoglycemia & Management of Diabetes in CKD Stage V
Ma Wady
 
Rapidly progressive renal failure
Rapidly progressive renal failureRapidly progressive renal failure
Rapidly progressive renal failure
Ankit Data
 
hemodialysis catheter infection
hemodialysis catheter infectionhemodialysis catheter infection
hemodialysis catheter infection
Muhamed Al Rohani
 
Surviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines UpdatedSurviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines Updated
Sun Yai-Cheng
 

What's hot (20)

Contrast Induced Nephropathy
Contrast Induced NephropathyContrast Induced Nephropathy
Contrast Induced Nephropathy
 
Sodium correction formula
Sodium correction formulaSodium correction formula
Sodium correction formula
 
Potassium Management
Potassium ManagementPotassium Management
Potassium Management
 
Surviving Sepsis Guidelines 2016
Surviving Sepsis Guidelines 2016Surviving Sepsis Guidelines 2016
Surviving Sepsis Guidelines 2016
 
Anticoagulation in neurosurgery heparin warfarin_ppt
Anticoagulation in neurosurgery heparin warfarin_pptAnticoagulation in neurosurgery heparin warfarin_ppt
Anticoagulation in neurosurgery heparin warfarin_ppt
 
hypokalemia, diagnosis and management
hypokalemia, diagnosis and managementhypokalemia, diagnosis and management
hypokalemia, diagnosis and management
 
Aldosterone in diabetes and other kidney diseases
Aldosterone in diabetes and other kidney diseasesAldosterone in diabetes and other kidney diseases
Aldosterone in diabetes and other kidney diseases
 
Esc 2020 guidelines for the management of acute coronary
Esc 2020 guidelines for the management of acute coronaryEsc 2020 guidelines for the management of acute coronary
Esc 2020 guidelines for the management of acute coronary
 
Sepsis and septic shock guidelines 2021. part 1
Sepsis and septic shock guidelines 2021. part 1Sepsis and septic shock guidelines 2021. part 1
Sepsis and septic shock guidelines 2021. part 1
 
Drug modification in crrt
Drug modification in crrt Drug modification in crrt
Drug modification in crrt
 
CONTRAST INDUCED NEPHROPATHY(CI-AKI)
CONTRAST INDUCED NEPHROPATHY(CI-AKI)CONTRAST INDUCED NEPHROPATHY(CI-AKI)
CONTRAST INDUCED NEPHROPATHY(CI-AKI)
 
Contrast Nephropathy AKI
Contrast Nephropathy AKI  Contrast Nephropathy AKI
Contrast Nephropathy AKI
 
Novel Oral Anticoagulants (NOACs) in CKD & Dialysis Patients - How to Use? Wh...
Novel Oral Anticoagulants (NOACs) in CKD & Dialysis Patients - How to Use? Wh...Novel Oral Anticoagulants (NOACs) in CKD & Dialysis Patients - How to Use? Wh...
Novel Oral Anticoagulants (NOACs) in CKD & Dialysis Patients - How to Use? Wh...
 
Sepsis presentation by shami
Sepsis presentation by shami Sepsis presentation by shami
Sepsis presentation by shami
 
Anemia in CKD
Anemia in CKDAnemia in CKD
Anemia in CKD
 
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEFSimultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
 
Hypoglycemia & Management of Diabetes in CKD Stage V
Hypoglycemia & Management of Diabetes in CKD Stage VHypoglycemia & Management of Diabetes in CKD Stage V
Hypoglycemia & Management of Diabetes in CKD Stage V
 
Rapidly progressive renal failure
Rapidly progressive renal failureRapidly progressive renal failure
Rapidly progressive renal failure
 
hemodialysis catheter infection
hemodialysis catheter infectionhemodialysis catheter infection
hemodialysis catheter infection
 
Surviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines UpdatedSurviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines Updated
 

Similar to Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

How to approach hypercalcaemia?
How to approach hypercalcaemia?How to approach hypercalcaemia?
How to approach hypercalcaemia?
Adeel Rafi Ahmed
 
Hypercalcemia ,causes and treatment
Hypercalcemia ,causes and treatment Hypercalcemia ,causes and treatment
Hypercalcemia ,causes and treatment
anilapasha
 
Hyperparathyroidism.pptx
Hyperparathyroidism.pptxHyperparathyroidism.pptx
Hyperparathyroidism.pptx
ssuserf945541
 
parathyroid-Illuminata.pptx
parathyroid-Illuminata.pptxparathyroid-Illuminata.pptx
parathyroid-Illuminata.pptx
Mkindi Mkindi
 
disordersoftheparathyroidglands-141113110252-conversion-gate02.pdf
disordersoftheparathyroidglands-141113110252-conversion-gate02.pdfdisordersoftheparathyroidglands-141113110252-conversion-gate02.pdf
disordersoftheparathyroidglands-141113110252-conversion-gate02.pdf
MayureshChavan16
 
Hypercalcemia, causes and treatment
Hypercalcemia, causes and treatmentHypercalcemia, causes and treatment
Hypercalcemia, causes and treatment
anilapasha
 
Hypercalcemia.ppt
Hypercalcemia.pptHypercalcemia.ppt
Hypercalcemia.ppt
pradeepsingh855
 
disordersoftheparathyroidglands-141113110252-conversion-gate02 (1).pdf
disordersoftheparathyroidglands-141113110252-conversion-gate02 (1).pdfdisordersoftheparathyroidglands-141113110252-conversion-gate02 (1).pdf
disordersoftheparathyroidglands-141113110252-conversion-gate02 (1).pdf
MayureshChavan16
 
Parathyroid and calcium metabolism
Parathyroid and calcium metabolismParathyroid and calcium metabolism
Parathyroid and calcium metabolism
TAJ JAMSHAD
 
Calcim imbalances
Calcim imbalancesCalcim imbalances
Calcim imbalances
AnjaliNaudiyal1
 
Testing parathyroid hormone disorders.pptx
Testing parathyroid hormone disorders.pptxTesting parathyroid hormone disorders.pptx
Testing parathyroid hormone disorders.pptx
SayyedaReemFatema
 
Parathyroid Gland and its Disorders
Parathyroid Gland and its DisordersParathyroid Gland and its Disorders
Parathyroid Gland and its Disorders
Manish Shetty
 
Oncologic emergencies
Oncologic emergenciesOncologic emergencies
Oncologic emergencies
larriva
 
Hypercalcemia- Approach to the Diagnosis Palak Choksi.pptx
Hypercalcemia- Approach to the Diagnosis Palak Choksi.pptxHypercalcemia- Approach to the Diagnosis Palak Choksi.pptx
Hypercalcemia- Approach to the Diagnosis Palak Choksi.pptx
Mahdisalimi8
 
Hypercalcemia- Approach to the Diagnosis Palak Choksi.pptx
Hypercalcemia- Approach to the Diagnosis Palak Choksi.pptxHypercalcemia- Approach to the Diagnosis Palak Choksi.pptx
Hypercalcemia- Approach to the Diagnosis Palak Choksi.pptx
HedaiaMustafa
 
Acute kidney injury in pediatrics
Acute kidney injury in pediatricsAcute kidney injury in pediatrics
Acute kidney injury in pediatrics
Virendra Hindustani
 
CALCIUM,PHOSPHATE,VIT-D,PARATHYROID
CALCIUM,PHOSPHATE,VIT-D,PARATHYROIDCALCIUM,PHOSPHATE,VIT-D,PARATHYROID
CALCIUM,PHOSPHATE,VIT-D,PARATHYROID
Irshad Ali
 
Parathyroid gland
Parathyroid glandParathyroid gland
Parathyroid gland
Navneet Randhawa
 
Acute renal failure in children
Acute renal failure in childrenAcute renal failure in children
Acute renal failure in children
Abhijeet Deshmukh
 
Diseases of parathyroid &amp; adrenal glands
Diseases of parathyroid &amp; adrenal glandsDiseases of parathyroid &amp; adrenal glands
Diseases of parathyroid &amp; adrenal glands
OmarAlaidaroos3
 

Similar to Managing hypercalcaemia presented on CMC, Kol, 1.10.2013 (20)

How to approach hypercalcaemia?
How to approach hypercalcaemia?How to approach hypercalcaemia?
How to approach hypercalcaemia?
 
Hypercalcemia ,causes and treatment
Hypercalcemia ,causes and treatment Hypercalcemia ,causes and treatment
Hypercalcemia ,causes and treatment
 
Hyperparathyroidism.pptx
Hyperparathyroidism.pptxHyperparathyroidism.pptx
Hyperparathyroidism.pptx
 
parathyroid-Illuminata.pptx
parathyroid-Illuminata.pptxparathyroid-Illuminata.pptx
parathyroid-Illuminata.pptx
 
disordersoftheparathyroidglands-141113110252-conversion-gate02.pdf
disordersoftheparathyroidglands-141113110252-conversion-gate02.pdfdisordersoftheparathyroidglands-141113110252-conversion-gate02.pdf
disordersoftheparathyroidglands-141113110252-conversion-gate02.pdf
 
Hypercalcemia, causes and treatment
Hypercalcemia, causes and treatmentHypercalcemia, causes and treatment
Hypercalcemia, causes and treatment
 
Hypercalcemia.ppt
Hypercalcemia.pptHypercalcemia.ppt
Hypercalcemia.ppt
 
disordersoftheparathyroidglands-141113110252-conversion-gate02 (1).pdf
disordersoftheparathyroidglands-141113110252-conversion-gate02 (1).pdfdisordersoftheparathyroidglands-141113110252-conversion-gate02 (1).pdf
disordersoftheparathyroidglands-141113110252-conversion-gate02 (1).pdf
 
Parathyroid and calcium metabolism
Parathyroid and calcium metabolismParathyroid and calcium metabolism
Parathyroid and calcium metabolism
 
Calcim imbalances
Calcim imbalancesCalcim imbalances
Calcim imbalances
 
Testing parathyroid hormone disorders.pptx
Testing parathyroid hormone disorders.pptxTesting parathyroid hormone disorders.pptx
Testing parathyroid hormone disorders.pptx
 
Parathyroid Gland and its Disorders
Parathyroid Gland and its DisordersParathyroid Gland and its Disorders
Parathyroid Gland and its Disorders
 
Oncologic emergencies
Oncologic emergenciesOncologic emergencies
Oncologic emergencies
 
Hypercalcemia- Approach to the Diagnosis Palak Choksi.pptx
Hypercalcemia- Approach to the Diagnosis Palak Choksi.pptxHypercalcemia- Approach to the Diagnosis Palak Choksi.pptx
Hypercalcemia- Approach to the Diagnosis Palak Choksi.pptx
 
Hypercalcemia- Approach to the Diagnosis Palak Choksi.pptx
Hypercalcemia- Approach to the Diagnosis Palak Choksi.pptxHypercalcemia- Approach to the Diagnosis Palak Choksi.pptx
Hypercalcemia- Approach to the Diagnosis Palak Choksi.pptx
 
Acute kidney injury in pediatrics
Acute kidney injury in pediatricsAcute kidney injury in pediatrics
Acute kidney injury in pediatrics
 
CALCIUM,PHOSPHATE,VIT-D,PARATHYROID
CALCIUM,PHOSPHATE,VIT-D,PARATHYROIDCALCIUM,PHOSPHATE,VIT-D,PARATHYROID
CALCIUM,PHOSPHATE,VIT-D,PARATHYROID
 
Parathyroid gland
Parathyroid glandParathyroid gland
Parathyroid gland
 
Acute renal failure in children
Acute renal failure in childrenAcute renal failure in children
Acute renal failure in children
 
Diseases of parathyroid &amp; adrenal glands
Diseases of parathyroid &amp; adrenal glandsDiseases of parathyroid &amp; adrenal glands
Diseases of parathyroid &amp; adrenal glands
 

More from dibufolio

Ecg dibbs 290321_fy1
Ecg dibbs 290321_fy1Ecg dibbs 290321_fy1
Ecg dibbs 290321_fy1
dibufolio
 
Cardiac decison making
Cardiac decison makingCardiac decison making
Cardiac decison making
dibufolio
 
Cardiology Opinion for Diabetic patients
Cardiology Opinion for Diabetic patientsCardiology Opinion for Diabetic patients
Cardiology Opinion for Diabetic patients
dibufolio
 
Cardiogenic shock
Cardiogenic shockCardiogenic shock
Cardiogenic shock
dibufolio
 
Coronary circulation
Coronary circulationCoronary circulation
Coronary circulation
dibufolio
 
Clinical Approach to Valvular heart dis
Clinical Approach to Valvular heart disClinical Approach to Valvular heart dis
Clinical Approach to Valvular heart dis
dibufolio
 
SGLT2i
SGLT2iSGLT2i
SGLT2i
dibufolio
 
ACUTE RHEUMATIC FEVER
ACUTE RHEUMATIC FEVERACUTE RHEUMATIC FEVER
ACUTE RHEUMATIC FEVER
dibufolio
 
HEART FAILURE MANAGEMENT
HEART FAILURE MANAGEMENTHEART FAILURE MANAGEMENT
HEART FAILURE MANAGEMENT
dibufolio
 
HEART FAILURE
HEART FAILUREHEART FAILURE
HEART FAILURE
dibufolio
 
Supraventricular tachycardia: ECG recognition and diagnosis
Supraventricular tachycardia: ECG recognition and diagnosisSupraventricular tachycardia: ECG recognition and diagnosis
Supraventricular tachycardia: ECG recognition and diagnosis
dibufolio
 
Svt mi 2018
Svt mi 2018Svt mi 2018
Svt mi 2018
dibufolio
 
Resistant hypertension
Resistant hypertensionResistant hypertension
Resistant hypertension
dibufolio
 
PROSTHETIC HEART VALVES
PROSTHETIC HEART VALVESPROSTHETIC HEART VALVES
PROSTHETIC HEART VALVES
dibufolio
 
2015 svt guideline final 19.10.2015
2015 svt guideline final 19.10.20152015 svt guideline final 19.10.2015
2015 svt guideline final 19.10.2015
dibufolio
 
surgical approach of cyanotic congenital heart disease
surgical approach of cyanotic congenital heart diseasesurgical approach of cyanotic congenital heart disease
surgical approach of cyanotic congenital heart disease
dibufolio
 
interpretation of hemodynamic data
interpretation of hemodynamic datainterpretation of hemodynamic data
interpretation of hemodynamic data
dibufolio
 
Dibu's approach to congenital heart disease
Dibu's approach to congenital heart diseaseDibu's approach to congenital heart disease
Dibu's approach to congenital heart disease
dibufolio
 
Understanding pacemakers
Understanding pacemakersUnderstanding pacemakers
Understanding pacemakers
dibufolio
 
Vit d and cv risks
Vit d and cv risksVit d and cv risks
Vit d and cv risks
dibufolio
 

More from dibufolio (20)

Ecg dibbs 290321_fy1
Ecg dibbs 290321_fy1Ecg dibbs 290321_fy1
Ecg dibbs 290321_fy1
 
Cardiac decison making
Cardiac decison makingCardiac decison making
Cardiac decison making
 
Cardiology Opinion for Diabetic patients
Cardiology Opinion for Diabetic patientsCardiology Opinion for Diabetic patients
Cardiology Opinion for Diabetic patients
 
Cardiogenic shock
Cardiogenic shockCardiogenic shock
Cardiogenic shock
 
Coronary circulation
Coronary circulationCoronary circulation
Coronary circulation
 
Clinical Approach to Valvular heart dis
Clinical Approach to Valvular heart disClinical Approach to Valvular heart dis
Clinical Approach to Valvular heart dis
 
SGLT2i
SGLT2iSGLT2i
SGLT2i
 
ACUTE RHEUMATIC FEVER
ACUTE RHEUMATIC FEVERACUTE RHEUMATIC FEVER
ACUTE RHEUMATIC FEVER
 
HEART FAILURE MANAGEMENT
HEART FAILURE MANAGEMENTHEART FAILURE MANAGEMENT
HEART FAILURE MANAGEMENT
 
HEART FAILURE
HEART FAILUREHEART FAILURE
HEART FAILURE
 
Supraventricular tachycardia: ECG recognition and diagnosis
Supraventricular tachycardia: ECG recognition and diagnosisSupraventricular tachycardia: ECG recognition and diagnosis
Supraventricular tachycardia: ECG recognition and diagnosis
 
Svt mi 2018
Svt mi 2018Svt mi 2018
Svt mi 2018
 
Resistant hypertension
Resistant hypertensionResistant hypertension
Resistant hypertension
 
PROSTHETIC HEART VALVES
PROSTHETIC HEART VALVESPROSTHETIC HEART VALVES
PROSTHETIC HEART VALVES
 
2015 svt guideline final 19.10.2015
2015 svt guideline final 19.10.20152015 svt guideline final 19.10.2015
2015 svt guideline final 19.10.2015
 
surgical approach of cyanotic congenital heart disease
surgical approach of cyanotic congenital heart diseasesurgical approach of cyanotic congenital heart disease
surgical approach of cyanotic congenital heart disease
 
interpretation of hemodynamic data
interpretation of hemodynamic datainterpretation of hemodynamic data
interpretation of hemodynamic data
 
Dibu's approach to congenital heart disease
Dibu's approach to congenital heart diseaseDibu's approach to congenital heart disease
Dibu's approach to congenital heart disease
 
Understanding pacemakers
Understanding pacemakersUnderstanding pacemakers
Understanding pacemakers
 
Vit d and cv risks
Vit d and cv risksVit d and cv risks
Vit d and cv risks
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
Donc Test
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
Gokuldas Hospital
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loopLOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
debosmitaasanyal1
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loopLOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 

Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

  • 1. Speaker: Dr. Dibbendhu Khanra Chairperson: Dr. A.K. Banerjee
  • 2. Calcium an unparallel hero  most abundant mineral of body  maintenance of strong bones  neuro-mascular action  blood clotting, blood pressure  hormone regulation -most over-the-counter sold drug - 43% Indian women on supplement - prescribed by doctors commonly
  • 3. Calciuma sinister in disguise HypercalcaemiaToday’s concern! ..Some cases.. 3
  • 4. Mr. K is a 41 year old patient – Mild depression – Behavioral abnormality – Headache – Fatigue – Difficulty concentrating – TSH - 2.06 (0.5 – 4.00) – calcium 12.4 mg/dl (8.4 – 10.4 mg/dl)
  • 5.  Mrs. C is a 57 year old patient, well  t-score – 1.3 (spine), 2. 8 (femur)  Calcium – 12. 5 (8.4 – 10.4 mg/dl)  weight loss and generalised weakness  Cough and hemoptysis
  • 6. • • • • • • • • A 58-year-woman presented to ER progressive Multiple sclerosis Osteoporosis calcium, 600 mg, 3 times daily 5000-IU cholecalciferol supplement OD tremors Altered sensorium serum calcium 15.2 mg/dL
  • 7. • • • • • • 30-year-old female Fever, cough Polyuria, polydypsia, GI upset constipation, confusion, headache CECT chest – hilar lympahedenopathy serum calcium, 13.8 mg/d
  • 8. • • • • • 50-year-old male Diabetic for 10 years Poorly controlled with OHA HTN, anasarca, anaemia serum calcium 14.8 mg/d
  • 9.       Calcium metabolism Defining hypercalcaemia Causes of hypercalcaemia Cl/f of hypercalceimia Diagnosis to hypercalcaemia Management
  • 10. 10
  • 11. 11
  • 12.
  • 13. 13
  • 17. A = high calcium levels means primary hyperparathyroidism unless the PTH is near zero B = normocalcemic" hyperparathyroidism. this is the only group that we believe should have a urinary calcium level performed
  • 18. It is IMPOSSIBLE to tell the difference between FHH and primary hyperparathyroidism based upon the results of a 24-hour urine test 1. Urinary calcium can be anything (very low to very high) in Pr HyperPTHism. 2. The arbitrary cut off of urinary ca excretion/ 24 hr 100 lacks any rationality. 3. Nor elevated serum ca neither elevated urinary ca has any association with renal stones. 4. Low urinary ca does not always mean FHH. FHH is so rare, that few doctors will ever see it. FHH is diagnosed incorrectly about 95-99% of the time
  • 19. Corrected serum calcium= Ionized calcium + 0.8(4-serum albumin) calcium is high and PTH is high, d/g is primary hyperparathyroidism. IF calcium Familial is mildly Hypocalciuric raised in background of Hypercalcemia Sestamibi highly elevated N-scan PTH, then urinary ca can be ordered to rule out FHH 19
  • 20. Neuropsychiatric complaints Calcium 12.4 mg/dl iPTH – 509 (12-72 pg/ml) Thallium subtraction study: Left lower lobe parathyroid adenoma
  • 21. Weight loss and generalised weakness Calcium – 12. 5 (8.4 – 10.4 mg/dl) iPTH 21 (10 – 65.0 pg/ml) PTHrp - elevated Lung biopsy with IHC: Well differentiated, low grade squamous cell lung carcinoma
  • 22. • • • • calcium, cholecalciferol supplement serum calcium14.6 mg/dL (15.2 mg/dL) iPTH - 4 pg/mL (N12-65 pg/mL 25-OH D level 103 ng/mL (N>30 ng/ml) Vit D overdose 22
  • 23. • • • • • CECT chest – hilar lympahedenopathy serum calcium, 13.8 mg/d iPTH - 4 pg/mL (N12-65 pg/mL 1, 25-OH D level elevated Serum ACEase – highly raised Hilar LN Bx – non caseating granulomas Sarcoidosis 23
  • 24. • • • • T2DM CKD serum calcium 14.8 mg/d iPTH – 209 (12-72 pg/ml) Hypercalcemia Associated with Renal Failure
  • 25. Hypercalcemia Associated with Renal Failure Secondary Hyperparathyroidism Hypocalcaemia is the common denominator Reversible (adaptive) growth of parathyroid gland • Resistance to the normal level of PTH • Increased level of FGF23 • Reduction in 1,25(OH)2 vitamin D Tertiary Hyperparathyroidism • Long-standing, inadequately treated chronic renal failure • True clonal outgrowth (irreversible) 25
  • 27. Critical - > 14 mg % 1 Moderate - 12 to 14 mg % 2 Mild – 10.4 to 11.9 mg % 3 • Aggressive therapy • Start therapy • When symptomatic • When PrHyperPTHism • No therapy • Except PrHyperPTHism Normal – 8.5 to 10.3 mg % Hypercalcaemia should always be treated 27
  • 28. - thiazide and lithium - volume depletion - prolonged bed rest or inactivity - high calcium diet (>1000 mg/day) 28
  • 30. Dr. Harold Copp isolated calcitonin from salmon sperm
  • 31. Bisphos phonate: MOA Osteonecrosis of Jaw (ONJ) mandible > maxilla Matrix metalloproteinase 2
  • 32. Treating hypercalcaemia is multidrug approach In HF, CKD; lowers ca by 1-3 mg/dl Routine use not recommended Do not give bisphosphonates until patient is fully rehydrated contraindicated in patients with cr cl <10 mL/min Caution with NSAIDS, ACE inhibitors, aminoglycosides Calcitonin and hydration provide a rapid reduction, while a bisphosphonate provides a sustained effect
  • 33. Monitoring Surgery • Serum calcium level  Mildly elevated calcium > 1 mg % above normal  No previous episodes of • Creatinine clearance life threatening hypercalcemia < 60 ml/minute  Normal renal function • Bone density: T score <–2.5  Normal bone status at Any of 3 sites • Age younger than 50 years Serum ca serum creatinine Bone density Significant symptoms – Rx surgery 33
  • 34. Minimally Invasive Parathyroidectomy (MIP)  an outpatient procedure  Pre-op localization with Sestamibi Tc scan  cervical block anesthesia  minimal surgical incision  Intra-op PTH level obtained before and 5 mins after removal  If PTH levels fall by greater than 50% operation terminated  IF PTH Levels fall by less than 50%, full neck exploration  clear-cut cost benefit  Accepted in asymptomatic patients  not proper for multiple tumour or large tumours
  • 35. • If an enlarged gland is found, a • all four glands be normal gland should be sought. sought • if an intra-operative frozen section biopsy of a normal-sized • most of the total parathyroid tissue second gland confirms its mass be removed. histologic normality, no further exploration, biopsy, or excision is • unnecessary surgery & un-acceptable rate needed. of hypoparathyroidism • recurrence rate of hyperand hypocalcamia. parathyroidism may be high if a second abnormal gland is missed. 35
  • 36. • totally remove three glands with partial excision of the fourth gland • care is taken to leave a good blood supply for the remaining gland • total parathyroidectomy with immediate transplantation of a portion of a removed, minced parathyroid gland into the muscles of the forearm • surgical excision is easier from the ectopic site in the arm if there is recurrent hyperfunction 36
  • 37.  calcium 12.4 mg/dl (8.4 – 10.4 mg/dl)  parathyroid adenoma  M/N= Surgery (MIP)
  • 38.  Malignancy related hypercalcaemia (Breast, Lung, Lymphoma, Thyroid, Kidney, Prostate, Multiple Myeloma)  N Saline  calcitonin  Zoledronic acid
  • 39. • Vit D overdose • Half life of Vit D is very short no further treatment required • Withhold Vit D • Steroid can be used 39
  • 40. • • • • Acute symptomatic hypercalcaemia Sarcoidosis (granulomatous disease; DHCC related) NS Steroid 40
  • 41. • Hypercalcemia Associated with Renal Failure • Secondary hyperparathyroidism • calcitriol
  • 42. • Dialysis if life threatening Secondary hyperparatyroidism • restriction of dietary phosphate, • the use of non-absorbable antacids • careful, selective addition of calcitriol Tertiary Hyperparatyroidism • Partial removal of parathyroid gland 42
  • 43. S U M M A R Y Dialysis Controversial Malignancy or Vit D associated cases Avoid factors that can aggravate hypercalcemia In CKD 43
  • 44. • Most common cause of hypercalcaemia is primary hyperparathyroidism • Any hypercalcaemia should be worked up and treated. • First investigation to seek for is an intact PTH • Surgery is often provided to apparently aysmptomtic patients of primary hyperparathyroidism • FHH, practically does NOT occur • Hydration is the mainstay of therapy • Managing hypercalcaemia is a multidrug approach • Calcitriol can be given in CKD associated hypercalaemia